Evidence map›Paper›PMID 18346044›Full record

ArticleBasic & clinical pharmacology & toxicology2008

Norsolorinic acid from Aspergillus nidulans inhibits the proliferation of human breast adenocarcinoma MCF-7 cells via Fas-mediated pathway.

Clay C C Wang, Yi-Ming Chiang, Po-Lin Kuo, Jiunn-Kae Chang, Ya-Ling Hsu

Open access · bronzeAbstract read
In one paragraph

Article in Basic & clinical pharmacology & toxicology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Clay C C WangDepartment of Pharmacology and Pharmaceutical Science, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
Yi-Ming Chiang
Po-Lin Kuo
Jiunn-Kae Chang
Ya-Ling Hsu
Chia Nan University of Pharmacy and Science · TWUniversity of Southern California · US

Funding

Platforms for nonribosomal peptide manipulation(RMI)R01GM075857 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, CLAY C · 2005 to 2007
$834k
NIGMS NIH HHS GM075857NIGMS NIH HHS R01 GM075857
6 · The paper itself

Abstract

Norsolorinic acid, isolated from the Aspergillus nidulans, was investigated for its antiproliferative activity in human breast adenocarcinoma MCF-7 cells. To identity the anticancer mechanism of norsolorinic acid, we assayed its effect on apoptosis, cell cycle distribution, and levels of p53, p21/WAF1, Fas/APO-1 receptor and Fas ligand. The results showed that norsolorinic acid induced apoptosis of MCF-7 cells without mediation of p53 and p21/WAF1. We suggest that Fas/Fas ligand apoptotic system is the main pathway of norsolorinic acid-mediated apoptosis of MCF-7 cells. Our study reports here for the first time that the activity of the Fas/Fas ligand apoptotic system may participate in the antiproliferative activity of norsolorinic acid in MCF-7 cells.

Indexed as

AdenocarcinomaAnthraquinonesAntineoplastic Agents, PhytogenicApoptosisAspergillusBiomarkers, TumorBreast NeoplasmsCell CycleCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorFas Ligand Proteinfas ReceptorFemaleHumansPlant ExtractsAnthraquinonesAntineoplastic Agents, PhytogenicBiomarkers, TumorFas Ligand Proteinfas Receptornorsolorinic acidPlant Extracts

Identifiers

PMID18346044
PMCPMC3754440
OpenAlexW2043935975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.